Publicly funded alcohol and other drug (AOD) treatment services in Australia provide services to assist people to address their problematic drug use through a range of treatments. Assistance may also be provided to support the family and friends of people using drugs.

The main findings about AOD treatment services in 2016–17—including information on clients, drugs of concern, and treatment provided—are available in the Alcohol and other drug treatment services in Australia 2016–17 detailed findings report.

This supplementary report presents key state and territory findings on clients, closed treatment episodes and treatment agencies in 2016–17. Client counts refer to those closed treatment episodes for which a valid statistical linkage key (SLK) has been supplied. No imputation has been applied to client counts in this section of the report.

The technical notes page provides details on the data, with further information available in the AODTS NMDS 2016–17 data quality statement. Key findings and details of scope, coverage, and data quality are available online. In addition, a series of supplementary tables accompanying the annual report  (tables with the prefix ‘S’) are also available.

Box 1.1: Key facts

In 2016–17:

  • a total of 836 publicly funded agencies provided data about services for clients seeking treatment services and support in Australia, ranging from 15 in the Australian Capital Territory to 318 in New South Wales
  • nationally, alcohol was the most common principal drug of concern (32% of episodes), and amphetamines the second most common (26% of episodes)
  • cannabis was the most common drug of concern in Queensland (33%), and amphetamines the most common in South Australia (37%) and Western Australia (36%)
  • nationally, counselling was the most common treatment type (40%), and was the most common in 5 of the 8 states and territories.

Over the 5-year period to 2016–17:

  • the number of publicly funded agencies providing data about services for clients seeking treatment and support rose from 714 to 836 agencies, an increase that was largely driven by increases in the number of reporting agencies in New South Wales (from 245 to 318), Queensland (from 133 to 168), and Western Australia (from 68 to 87)
  • nationally, the 4 most common principal drugs of concern remained consistent, with amphetamines continuing to increase as a proportion of closed treatment episodes, from 14% in 2012–13 to 26% nationally in 2016–17
  • nationally, counselling remained the most common main treatment type, with assessment only and withdrawal management remaining second and third most common, respectively.